Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report.

Onco Targets Ther

Department of Radiation Oncology, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Cheonan, Republic of Korea,

Published: February 2019

The incidence of large cell neuroendocrine carcinoma (LCNEC) of the lung is rare, and the treatment methods and prognosis for such patients are still subjects of debate. We report a case of a 78-year-old male LCNEC patient for whom stereotactic body radiation therapy was performed. A four-dimensional computed tomography scan was used for simulation, and radiotherapy was planned using the volumetrically modulated arc technique. A total of 55 Gy was delivered in five daily fractions. The treatment was safely completed, and the patient did not report any discomfort. The only side-effect was an intermittent cough. Currently, the patient has received 18 months of outpatient follow-up care with no evidence of disease. In conclusion, stereotactic body radiation therapy can be a valuable treatment option for early stage LCNEC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388991PMC
http://dx.doi.org/10.2147/OTT.S189858DOI Listing

Publication Analysis

Top Keywords

stereotactic body
12
body radiation
12
radiation therapy
12
large cell
8
cell neuroendocrine
8
neuroendocrine carcinoma
8
therapy pulmonary
4
pulmonary large
4
carcinoma case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!